Ons doen dus stappe om sterftesyfers onder moeders te verlaag, om nuwe MIV-infeksies te verminder en om MIV en tuberkulose effektief te behandel.
We are therefore making interventions to lower maternal mortality rates, to reduce new HIV infections and to effectively treat HIV and tuberculosis.